ARCB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ArcBest Corp (ARCB) is not a strong buy for a beginner investor with a long-term strategy at this time. While technical indicators suggest bullish momentum, the company's financial performance is deteriorating, and there are no significant positive catalysts to support a long-term investment. Hold off on buying until there is evidence of improved financials or stronger growth prospects.
The technical indicators show bullish momentum with the MACD histogram positively expanding at 1.441, RSI_6 at 81.659 indicating overbought conditions, and bullish moving averages (SMA_5 > SMA_20 > SMA_200). Key resistance is at 117.284, and support is at 99.704. However, the overbought RSI suggests caution.
Insider buying has increased significantly by 284.68% over the last month, suggesting confidence from company insiders. Analysts like Citi and Jefferies have raised price targets, indicating some optimism about the stock.
showed a YoY revenue drop of -2.89%, net income dropped to -$8.1M (-127.95% YoY), and EPS dropped to -0.36 (-129.27% YoY).
ArcBest's financial performance is weak. In Q4 2025, revenue dropped to $972.69M (-2.89% YoY), net income fell to -$8.12M (-127.95% YoY), and EPS declined to -0.36 (-129.27% YoY). Gross margin also decreased to 80.83 (-2.30% YoY). These trends indicate a deteriorating financial position.
Analysts are mixed on ArcBest. Stifel, Citi, and Jefferies have Buy ratings with price targets ranging from $116 to $125, indicating some optimism. However, JPMorgan and BofA maintain Neutral ratings, citing macro uncertainty and slow volume growth. The consensus suggests cautious optimism but no strong conviction for long-term growth.
